Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.

Standard

Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study. / Forlenza, Orestes V; Wacker, Priscilla; Nunes, Paula V; Yacubian, Juliana; Castro, Claudio C; Otaduy, Maria C G; Gattaz, Wagner F.

in: PSYCHOPHARMACOLOGY, Jahrgang 180, Nr. 2, 2, 2005, S. 359-365.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Forlenza, OV, Wacker, P, Nunes, PV, Yacubian, J, Castro, CC, Otaduy, MCG & Gattaz, WF 2005, 'Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.', PSYCHOPHARMACOLOGY, Jg. 180, Nr. 2, 2, S. 359-365. <http://www.ncbi.nlm.nih.gov/pubmed/15700180?dopt=Citation>

APA

Forlenza, O. V., Wacker, P., Nunes, P. V., Yacubian, J., Castro, C. C., Otaduy, M. C. G., & Gattaz, W. F. (2005). Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study. PSYCHOPHARMACOLOGY, 180(2), 359-365. [2]. http://www.ncbi.nlm.nih.gov/pubmed/15700180?dopt=Citation

Vancouver

Forlenza OV, Wacker P, Nunes PV, Yacubian J, Castro CC, Otaduy MCG et al. Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study. PSYCHOPHARMACOLOGY. 2005;180(2):359-365. 2.

Bibtex

@article{3d5f57854f044555a8abc6396065192f,
title = "Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.",
abstract = "BACKGROUND: Abnormalities of membrane phospholipid metabolism have been described in Alzheimer's disease (AD). We investigated, with the aid of (31)P magnetic resonance spectroscopy, the in vivo intracerebral availability of phosphomonoesters (PME) and phosphodiesters (PDE) in patients with AD. METHODS: Eighteen outpatients with mild or moderate probable AD and 16 nondemented elderly volunteers were assessed with the Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) and its cognitive subscale of the CAMDEX schedule (CAMCOG). Scans were performed on a 1.5 T magnetic resonance imager addressing a 40-cm(3) voxel in the left prefrontal cortex. Main outcome measures were mean relative peak areas of PME and PDE, which provide an estimate of membrane phospholipid metabolism. RESULTS: PME resonance and the PME/PDE ratio were increased in AD patients as compared to controls (p",
author = "Forlenza, {Orestes V} and Priscilla Wacker and Nunes, {Paula V} and Juliana Yacubian and Castro, {Claudio C} and Otaduy, {Maria C G} and Gattaz, {Wagner F}",
year = "2005",
language = "Deutsch",
volume = "180",
pages = "359--365",
journal = "PSYCHOPHARMACOLOGY",
issn = "0033-3158",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Reduced phospholipid breakdown in Alzheimer's brains: a 31P spectroscopy study.

AU - Forlenza, Orestes V

AU - Wacker, Priscilla

AU - Nunes, Paula V

AU - Yacubian, Juliana

AU - Castro, Claudio C

AU - Otaduy, Maria C G

AU - Gattaz, Wagner F

PY - 2005

Y1 - 2005

N2 - BACKGROUND: Abnormalities of membrane phospholipid metabolism have been described in Alzheimer's disease (AD). We investigated, with the aid of (31)P magnetic resonance spectroscopy, the in vivo intracerebral availability of phosphomonoesters (PME) and phosphodiesters (PDE) in patients with AD. METHODS: Eighteen outpatients with mild or moderate probable AD and 16 nondemented elderly volunteers were assessed with the Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) and its cognitive subscale of the CAMDEX schedule (CAMCOG). Scans were performed on a 1.5 T magnetic resonance imager addressing a 40-cm(3) voxel in the left prefrontal cortex. Main outcome measures were mean relative peak areas of PME and PDE, which provide an estimate of membrane phospholipid metabolism. RESULTS: PME resonance and the PME/PDE ratio were increased in AD patients as compared to controls (p

AB - BACKGROUND: Abnormalities of membrane phospholipid metabolism have been described in Alzheimer's disease (AD). We investigated, with the aid of (31)P magnetic resonance spectroscopy, the in vivo intracerebral availability of phosphomonoesters (PME) and phosphodiesters (PDE) in patients with AD. METHODS: Eighteen outpatients with mild or moderate probable AD and 16 nondemented elderly volunteers were assessed with the Cambridge Examination for Mental Disorders of the Elderly (CAMDEX) and its cognitive subscale of the CAMDEX schedule (CAMCOG). Scans were performed on a 1.5 T magnetic resonance imager addressing a 40-cm(3) voxel in the left prefrontal cortex. Main outcome measures were mean relative peak areas of PME and PDE, which provide an estimate of membrane phospholipid metabolism. RESULTS: PME resonance and the PME/PDE ratio were increased in AD patients as compared to controls (p

M3 - SCORING: Zeitschriftenaufsatz

VL - 180

SP - 359

EP - 365

JO - PSYCHOPHARMACOLOGY

JF - PSYCHOPHARMACOLOGY

SN - 0033-3158

IS - 2

M1 - 2

ER -